Logo
investor hub

Position Statement: Pentosan Polysulfate Sodium (PPS) and Pigmentary Maculopathy (PM)

Source: Paradigm Biopharma

December 16, 2025


0

likes

0

questions

0

company answers

Ask a question


Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Paradigm Biopharmaceuticals a question about this update.